Hepatitis B Therapy
Differentially expressed genes are targets for hepatitis B containment
Published in Hepatitis Weekly, August 15th, 2005
According to recent research published in the Journal of Viral Hepatitis, "the aim of the study was to screen for cellular genes that are differentially expressed following hepatitis B virus (HBV) infection, in an attempt to identify potential targets of anti-HBV drugs. An oligonucleotide microarray containing 231 virus-infection-associated genes was prepared."
"Differential gene expression in HepG2.2.15 cells compared to control with HepG2 cells was analyzed by this in-house microarray. The change in gene expression in HepG2.2.15 cells treated by lamivudine on days 4 and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-08-15)
More Articles from Hepatitis Weekly
- Chronic Hepatitis B
Lamivudine-induced seroconversion after hepatitis B relapse is short-lived - Fatty Liver Disease
Weight loss after bariatric surgery helps obese patients clear liver steatosis - Hepatitis B Therapy
Lentiviral vectors containing hammerhead ribozymes end hepatitis B activity - Hepatitis C Virus
Liver transplant recipients with hepatitis C require lower doses of tacrolimus - Oncogenesis
Hepatitis C may trigger B-cell disorders through CD81 and E2 interaction - Business & Finance
Biopharmaceutical company reports second quarter 2005 results - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
